Cellpeuticssp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2015-12-11
Share capital
20,000.00 PLN
Registered address
ul. Duńska 9, 54-427 Wrocław, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 144 days for 2021).
- 2025not filed
- 202403/05/2025
- 202314/07/2024
- 202205/03/2023
- 202106/12/2022
- 202004/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Industry · Other research and experimental development on natural sciences and engineering1,436 / 1,565
Top 92%
Voivodeship · Dolnośląskie38,930 / 41,332
Top 94%
Country · Poland466,228 / 495,860
Top 94%
Results vs industry
Revenue
This companyUSD 151.48MedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD -8.43kMedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 3.63kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 344.72kMedianUSD 119.88kAverageUSD 3.90m
Industry
Public procurement
2 tenders recorded as contracting authority.
Notices (contracting authority)
| Publication date | Subject | Amount | Type | |
|---|---|---|---|---|
| Sep 21, 2018 | Poland-Wrocław: Medical kits | –– | Contract award notice | |
| Sep 30, 2016 | Poland-Wrocław: Medical kits | –– | Contract notice |
Authorized Representatives
Vladimír Bobek – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Vladimír Bobekage 52 | – | $2,755.27 | 51% |
Katarina Kolostova | 98 | $2,647.22 | 49% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 9, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $14,526$14,526 | Wrocławska Agencja Rozwoju Regionalnego S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2016-07-01 | Circulating sporadic cells in the diagnosis and treatment of endometriosis. | $700.9K$700,885 | Regional Operational Programme for the Lower Silesian Voivodeship 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Navalgosp. z o.o. | $849,375.69 | navalgo.com | ||
| MedisensonicS.A. | $362,572.63 | medisensonic.com | ||
| 123labs.Eusp. z o.o. | $88,497.45 | 123labs.eu | ||
| Aliatechnicssp. z o.o. | $65,787.92 | aliatechnics.pl | ||
| Sigmatiksp. z o.o. | $55,752.79 | sigmatik.com | ||
| Deepstributedsp. z o.o. | $20,321.35 | deepstributed.com | ||
| Zero Analogsp. z o.o. | $4,398.35 | zero-analog.pl | ||
| Univectsp. z o.o. | $2,964.64 | univect.com | ||
| Bekarsp. z o.o. | $2,532.65 | bekar.pl | ||
| Quetzsp. z o.o. | $465.02 | quetz.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-02-22 | Address change (Ul. Duńska 9, 54-424, Wrocław → Ul. Duńska 9, 54-427, Wrocław) | |
| 2015-12-11 | Entered in the register |
FAQ
The main business activity of Cellpeutics focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on December 11, 2015.
The headquarters is located at: ul. Duńska 9, 54-427 Wrocław.
The share capital of the company is PLN 20,000 (approx. $5,402).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $151 in 2024, which is a decrease of 89.2% compared to 2023.
No, the company recorded a net loss of $8,434 in 2024. For comparison, in 2023 the loss was $28,463, meaning the company reduced its loss by 71.9%.
Last updated: 2026-04-15
